Back to CELG-RI
MACKENZIE FINANCIAL CORP → CELG-RI
MACKENZIE FINANCIAL CORP CELG-RI Position History
Bristol-Myers Squibb Company Ce • Healthcare
Quarters held
6
Latest value
$129.8M
Q3 2026
Peak value
$129.8M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $56.6M |
| Q4 2025 | $60M |
| Q4 2025 | $8K |
| Q1 2026 | $88.9M |
| Q2 2026 | $118.9M |
| Q3 2026 | $129.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $129.8M | 2.08M | — | — |
| Q2 2026 | $118.9M | 2.06M | — | — |
| Q1 2026 | $88.9M | 1.47M | — | — |
| Q4 2025 | $8K | 18.5K | — | — |
| Q4 2025 | $60M | 1.11M | — | — |
| Q3 2025 | $56.6M | 1.25M | — | — |
Other funds holding CELG-RI
$11.1B
$9.6B
$8.5B
$7.9B
$5.9B
$5.9B
$5.8B